Switch to:
Array BioPharma Inc (NAS:ARRY)
Beneish M-Score
-2.65 (As of Today)

The zones of discrimination for M-Score is as such:

An M-Score of less than -2.22 suggests that the company is not an accounting manipulator.
An M-Score of greater than -2.22 signals that the company is likely an accounting manipulator.

Array BioPharma Inc has a M-score of -2.65 suggests that the company is not a manipulator.

ARRY' s Beneish M-Score Range Over the Past 10 Years
Min: -10000000   Max: 10000000
Current: -2.65

-10000000
10000000

During the past 13 years, the highest Beneish M-Score of Array BioPharma Inc was 10000000.00. The lowest was -10000000.00. And the median was -2.68.


Definition

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Z-Score) or business trend (F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Array BioPharma Inc for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.2306+0.528 * -1.0508+0.404 * 0.3278+0.892 * 1.829+0.115 * 0.8925
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.7435+4.679 * 0.0231-0.327 * 0.7078
=-2.65

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

This Year (Sep15) TTM:Last Year (Sep14) TTM:
Accounts Receivable was $13.50 Mil.
Revenue was 16.197 + 12.32 + 6.601 + 26.919 = $62.04 Mil.
Gross Profit was 9.985 + 5.343 + -5.539 + 13.821 = $23.61 Mil.
Total Current Assets was $179.60 Mil.
Total Assets was $186.75 Mil.
Property, Plant and Equipment(Net PPE) was $4.99 Mil.
Depreciation, Depletion and Amortization(DDA) was $3.30 Mil.
Selling, General & Admin. Expense(SGA) was $31.99 Mil.
Total Current Liabilities was $49.26 Mil.
Long-Term Debt was $108.81 Mil.
Net Income was -20.987 + -12.734 + 58.307 + -8.611 = $15.98 Mil.
Non Operating Income was 0 + 11.494 + 6.402 + 0 = $17.90 Mil.
Cash Flow from Operations was -19.204 + -27.265 + 38.255 + 1.986 = $-6.23 Mil.
Accounts Receivable was $6.00 Mil.
Revenue was 6.069 + 6.011 + 7.773 + 14.066 = $33.92 Mil.
Gross Profit was -6.108 + -5.43 + -2.983 + 0.956 = $-13.57 Mil.
Total Current Assets was $122.79 Mil.
Total Assets was $135.33 Mil.
Property, Plant and Equipment(Net PPE) was $7.76 Mil.
Depreciation, Depletion and Amortization(DDA) was $4.28 Mil.
Selling, General & Admin. Expense(SGA) was $23.53 Mil.
Total Current Liabilities was $56.57 Mil.
Long-Term Debt was $105.26 Mil.



1. DSRI = Days Sales in Receivables Index

Measured as the ratio of days’ sales in receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(13.504 / 62.037) / (6 / 33.919)
=0.21767655 / 0.17689201
=1.2306

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(5.343 / 33.919) / (9.985 / 62.037)
=-0.39992335 / 0.38057933
=-1.0508

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than plant, property and equipment to total assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (179.603 + 4.988) / 186.752) / (1 - (122.787 + 7.764) / 135.328)
=0.0115715 / 0.03529942
=0.3278

4. SGI = Sales Growth Index

Ratio of sales in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=62.037 / 33.919
=1.829

5. DEPI = Depreciation Index

Measured as the ratio of the rate of depreciation in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(4.279 / (4.279 + 7.764)) / (3.299 / (3.299 + 4.988))
=0.35531014 / 0.3980934
=0.8925

6. SGAI = Sales, General and Administrative expenses Index

The ratio of SGA expenses in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(31.992 / 62.037) / (23.527 / 33.919)
=0.51569225 / 0.69362304
=0.7435

7. LVGI = Leverage Index

The ratio of total debt to total assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase$sgai= in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((108.813 + 49.261) / 186.752) / ((105.263 + 56.569) / 135.328)
=0.84643806 / 1.19585008
=0.7078

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(15.975 - 17.896 - -6.228) / 186.752
=0.0231

An M-Score of less than -2.22 suggests that the company will not be a manipulator. An M-Score of greater than -2.22 signals that the company is likely to be a manipulator.

Array BioPharma Inc has a M-score of -2.65 suggests that the company will not be a manipulator.


Related Terms

Altman Z-Score, Piotroski F-Score, Accounts Receivable, Revenue, Gross Profit, Total Current Assets, Total Assets, Property, Plant and Equipment, Depreciation, Depletion and Amortization, Selling, General & Admin. Expense, Total Current Liabilities, Long-Term Debt, Net Income, Non Operating Income, Cash Flow from Operations


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Array BioPharma Inc Annual Data

Jun06Jun07Jun08Jun09Jun10Jun11Jun12Jun13Jun14Jun15
DSRI 2.0209240.9641011110.92090.93560.9417
GMI 1.36771.25971.25910.43270.79340.83611.2595-6.1458-0.6379
AQI 023.0071.26090.5170.2710.7721.26581.46010.2141
SGI 0.98890.77920.86722.15681.33451.18410.81730.60471.2336
DEPI 0.82110.97750.94830.87450.69911.10270.98060.8490.8413
SGAI 1.48771.46651.33280.44050.71170.78961.57951.8461.1631
LVGI 1.58181.89172.91330.96161.50510.86210.70751.02630.669
TATA -0.1499-0.2985-0.1803-0.60620.15760.10090.2671-0.0994-0.0138
M-score -2.76225.35-4.81-4.68-2.00-1.937.97-7.12-3.51

Array BioPharma Inc Quarterly Data

Sep13Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15
DSRI 1110.935611.85821.16280.64360.94171.23068.8047
GMI 1.39071.70171.6873-6.1458-1.2425-25.4678-4.5448-0.6379-1.0508-0.0267
AQI 1.82612.9032.88641.46010.57780.45740.30810.21410.32780.3976
SGI 0.86220.86050.94840.60470.4990.73470.74171.23361.8291.5083
DEPI 0.91930.85880.80970.8490.90121.0471.11010.84130.89251.0088
SGAI 1.42811.42031.191.84592.35461.70311.83121.16310.74350.8588
LVGI 0.53260.8470.78981.02631.20021.11710.66740.6690.70780.7663
TATA 0.07960.07160.0004-0.0994-0.0579-0.2152-0.0565-0.01380.02310.1651
M-score -1.62-1.17-1.38-7.125.13-17.92-6.53-3.51-2.655.24
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK